Viewing Study NCT03348059


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-01-11 @ 11:44 PM
Study NCT ID: NCT03348059
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2017-11-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module